The control of ifosfamide-induced hematuria with N-acetylcysteine in patients with advanced carcinoma of the lung.
D000111:Acetylcysteine / Q000627:therapeutic use*; D000284:Administration, Oral; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D005260:Female; D006417:Hematuria / Q000517:prevention & control*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D011897:Random Allocation
D003520:Cyclophosphamide; D007069:Ifosfamide; D000111:Acetylcysteine